Connect with us

Technology

Global Health Exhibition Opens its Doors Tomorrow to Record-Breaking 100,000+ Attendees to World’s Premier Healthcare Transformation Event

Published

on

Kingdom of Saudi Arabia opens the Global Health Exhibition (21-23 October 2024) tomorrow, a major international healthcare event with 100,000+ health and patient care stakeholders in attendance alongside over 1,200 exhibiting companies and brands, including Abbott, Baxter, Siemens, Zimmer Biomet, Johnson & Johnson and many moreExhibition features over 500 expert speakers across five healthcare disciplines, introducing frontier-pushing medical technology alongside 100 hours of accredited CME opportunities for medical professionals; as well as openings for healthcare startup businesses to capture the attention of investorsExhibition will offer attendees exposure to the latest artificial intelligence (AI) solutions being introduced to healthcare services, designed to transform the global medicine landscape alongside the latest augmented and virtual reality medical technologyExhibition sponsors include Saudi Commission for Health Specialities as the Strategic Partner; Health Holding, NUPCO, Mobily and Lean as Foundation Partners; STC as Digital Enabler; and Dallah Health and Tawuniya as Diamond SponsorsThe 7th Edition of the Global Health Exhibition is now set to become one of the top three most-attended healthcare forums worldwide

MALHAM, Saudi Arabia, Oct. 20, 2024 /PRNewswire/ — Tahaluf, organizers of the Global Health Exhibition, today announced advance registrations for the event opening in Riyadh tomorrow have surpassed expected attendance, making the international exhibition a major moment in the global healthcare professional and industry calendar.

The three-day exhibition, taking place in Malham, Riyadh under the patronage of the Saudi Arabia Ministry of Health, has more than doubled in size from its previous 2023 event, giving attendees access to an unprecedented number of world-leading healthcare and medical experts including Jeff Immelt, former CEO of General Electric and Venture Partner at New Enterprise Associates, Dr Mehmood Khan, CEO, Hevolution Foundation Saudi Arabia; Prof. Catherine Green OBE, Head of the Clinical BioManufacturing Facility at the University of Oxford; Dr Beth Healey, expedition doctor for National Geographic, clinical director at the University Hospitals of Geneva and former research MD for the European Space Agency; Dr Mariam Al Rashed Mehairbi, Regional Chief Medical Officer, Al Dhafra Hospitals; Dr Jose Pedro Almeida, a Chief AI Strategist and advisor, and one of the World’s Top 70 Global Health AI Brains and Dr Mohammad Al-Haddad MD, MSc, FASGE, FACG, AGAF, Division Director and Professor of Medicine at the IU School of Medicine. They will be joined by impressive Saudi leaders and healthcare experts including His Excellency Fahad bin Abdurrahman Al-Jalajel, Minister, Ministry of Health, Saudi Arabia;  Dr Aws bin Ibrahim Al-Shamsan, Secretary General, Saudi Commission for Health Specialities (SCFHS) and Fahad M. Alshebel, CEO, NUPCO.

The Exhibition’s sponsors include Saudi Commission for Health Specialities as the Strategic Partner, Health Holding, NUPCO, Mobily and Lean as Foundation Partners, STC as Digital Enabler and Dallah Health and Tawuniya as Diamond Sponsors.

Experts will discuss boundary-pushing trends in AI and digital technology set to evolve the global healthcare landscape, under its organizing theme ‘Invest in Health’.

“The Saudi Commission for Health Specialties (SCFHS) is steadfast in its mission to redefine healthcare education through the integration of innovative strategies and state-of-the-art technologies,” said Professor Aws Al-Shamsan, Secretary-General, Saudi Commission for Health Specialties.

“At the 2024 Global Health Exhibition, themed ‘Invest in Health’, we are championing the development of AI-powered training modules and systems designed to equip practitioners with the advanced skills and expertise necessary to navigate the complexities of a rapidly evolving healthcare landscape”, he continued. “By harnessing AI-driven insights, healthcare practitioners can improve patient care and optimize operational efficiency, ensuring they are well-prepared for the future of the industry.”

The Global Health Exhibition will comprise of five specific conferences along with exclusive masterclasses for attendees.

The Leaders’ Summit will host 1,000 delegates daily, featuring major announcements, ministerial sessions outlining the future vision for Saudi Arabia’s healthcare sector, and insights from innovators, changemakers, international policymakers, and leading global industry CEOs. Speakers will include leaders from the Africa Centre for Diseases Control and Prevention, Mayo Clinic, University of Oxford, Mass General Brigham, World Health Organisation, Dana-Farber Cancer Institute, the NHS and The Organisation for Economic Co-operation and Development.

A Medical Excellence Forum will cover technical advancements in clinical laboratory practices and diagnostics, the personalization of medicine to improve patient outcomes, and strategies for attracting and retaining healthcare talent for excellence in nursing and workforce. The forum will hear from Bumrungrad Hospital International, Johnson & Johnson Innovative Medicine, Philips, Massachusetts General Hospital, Harvard Medical School, University Health Network Canada and Siemens Healthineers. Insights will be aimed at a diverse audience of healthcare professionals from clinicians, doctors and nurses through to diagnostic imaging specialists and surgeons.

A new Digital Health Forum driven by Saudi Arabia’s Vision 2030 to advance digital healthcare solutions will explore the optimization of healthcare intelligence including the transformative potential of AI diagnostics, the leveraging of health data insights to enhance patient outcomes, and the future of technology roadmaps to assist healthcare providers to offer patient-centric personalized care. Speakers will include experts from Northwell Health, Great Ormond Street Hospital, NHS Trusts, John Hopkins, Health Innovation Kent, M42 and Operose Health.

An Investor Forum will offer attendees the opportunity to explore the emerging global healthcare investment in Saudi Arabia. It will highlight the future investment and development strategies and prospects aligned with Vision 2030, highlight the current innovations in healthcare technology across vaccines, pharmaceuticals and healthcare devices, and explore the strengthening of the global healthcare supply chain. The forum will hear from 30+ investor speakers, including leaders from Bayer, Deerfield Management, ABRA Ventures, the Ministry of Investment, Seafund, Candesic and Hitachi Ventures.

A Health Transformation Forum will draw on technological advancements in promoting patient safety, accuracy and diagnostic outcomes across the three days. Day one will partner with the Saudi Patient Safety Centre to tackle the challenges, strategies and innovations involved in enhancing diagnostic safety; day two will partner with the Saudi Commission for Health Specialities to cover innovations in medical examinations, optimization in healthcare regulation, and cutting-edge accreditation processes, including virtual health hospitals, and day three will partner with The Centre for Value in Health to measure value by combining quantitative data with qualitative insights to drive better health outcomes.

The exhibition will also offer free exclusive masterclasses for attendees, including The Future Innovation of Diagnostics in Saudi Arabia hosted by Danaher, Building Next-Generation Healthcare Systems hosted by FTI Consulting, and Precision Exposomics / Genomics: Breakthrough Technology hosted by Novo Genomics. This will run alongside 100 hours of accredited CME workshops for medical professionals amongst attendees.

“Interest in this year’s Global Health Exhibition has significantly exceeded expectations and we are excited to be bringing such a vast array of healthcare talent, competence and passion to Riyadh for three days of interactive engagement,” said Rachel Sturgess, Group Director, Tahaluf.

“With a dual focus on the needs of medical professionals who care for patients daily and the booming health industry sector’s growing investment in Saudi Arabia, the stage is set for a pivotal moment in world medicine as we collectively reimagine what’s possible across digital and remote health provision, industry innovation and world class healthcare systems. It’s a unique opportunity for collaboration, to adapt best practice, and explore innovative solutions for tackling disease prevention, encouraging accessibility to the best health services and championing technology-driven innovation, with the aim of accelerating transformation in global healthcare and outcomes for patients.”

The event will also unveil the winners of the Vision NextGen competition, where startup health businesses will compete for a cash prize of a minimum of 100,000 SAR, incubation in the Regulatory Sandbox where 18 government and semi-government collaborate to enable innovation in healthcare, an exhibition booth at next year’s Global Health Exhibition, and invaluable networking opportunities. The Vision NextGen competition semi-finalists include a range of impressive and innovative healthcare businesses such as NoorDx Diagnostics and Discovery, RobotDreams, StoreGene, Stabilis Medical and Thriving.AI.

The increasing demand for healthcare services in Saudi Arabia is fuelling a need for advanced medical and healthcare services, offering vast market potential for global companies. The country is focusing on adopting cutting-edge technologies such as a strategic hub for reaching other emerging markets in the region, while their pharmaceutical market is expected to grow to $15.9 billion by 2027, driven by the $65 billion investment into healthcare infrastructure. Saudi Arabia contributes 60% of the GCC’s healthcare expenditure and is projected to see a 65% increase in private sector healthcare investment by 2030. The Global Health Exhibition is the gateway into Saudi Arabia’s booming healthcare market for the international healthcare world.

Registration information for Global Health Exhibition 2024 can be found at the following link: Global Health Exhibition (globalhealthsaudi.com)

View original content:https://www.prnewswire.co.uk/news-releases/global-health-exhibition-opens-its-doors-tomorrow-to-record-breaking-100-000-attendees-to-worlds-premier-healthcare-transformation-event-302281169.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Barrel Energy Inc. Announces Full SEC Reporting Status, Strengthening Marketability and Positioning Company for Expansion in Renewable and Nutritional Energy Markets

Published

on

By

Barrel Energy Inc. (OTC: BRLL) A fully reporting company. Accelerates Growth Across Energy, Hospitality, and Sustainable Ventures, Driving Scalable Opportunities Worldwide.

LAS VEGAS, May 11, 2026 /PRNewswire/ — Barrel Energy Inc. (OTC: BRLL), an emerging diversified energy company focused on renewable energy and nutritional energy initiatives, today announced that the Company is now a fully reporting company with the U.S. Securities and Exchange Commission (“SEC”), marking a major turning point in the Company’s long term growth strategy and public market development.

Barrel Energy Inc. Announces Full SEC Reporting Status, Strengthening Marketability and positioning for Expansion.

“Our transition to becoming a fully reporting SEC company represents a significant milestone for Barrel Energy and an important step toward increasing the overall marketability and visibility of our stock,” said Jarmin Kaltsas. “We believe today’s market increasingly rewards transparency and compliance, and becoming fully reporting positions us to engage a wider audience of investors, strategic partners, and acquisition opportunities as we continue executing our long term growth strategy under the BRLL trading symbol.”

Management further stated that the Company plans to aggressively pursue growth initiatives intended to expand revenues, strengthen market presence, and enhance shareholder value through strategic business combinations, operational expansion, and scalable energy focused ventures.

About Barrel Energy Inc.

Barrel Energy Inc. (OTC: BRLL) is a diversified energy company focused on opportunities in renewable energy, and nutritional energy initiatives. The Company seeks to leverage strategic acquisitions, public market growth, and innovative energy solutions to create long term shareholder value.

Forward-Looking Statements:

This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company’s periodic filings with the Security and Exchange Commission.

Barrel Energy – 3859 S. Valley View Blvd, STE 2 #107, Las Vegas, NV, 89103 Tel- 888- 397-9114 Email- info@BRLLenergy.com Social Media-@BRLLenergy all platforms.

View original content:https://www.prnewswire.com/news-releases/barrel-energy-inc-announces-full-sec-reporting-status-strengthening-marketability-and-positioning-company-for-expansion-in-renewable-and-nutritional-energy-markets-302768505.html

SOURCE Barrel Energy, Inc.

Continue Reading

Technology

Legacy Launches $1M Study Advancing At-Home Semen Collection for Assisted Reproduction Technology

Published

on

By

NEW YORK, May 11, 2026 /PRNewswire/ — Legacy, the leading male fertility clinic and at-home sperm testing and cryopreservation platform, today announced the Sperm Study, a clinical research initiative backed by an R&D investment of over $1 million and designed to evaluate and optimize the use of at-home semen collection for assisted reproductive technologies (ART), including IVF and IUI.

Prospectively enrolling up to 250 participants across two phases, this study represents one of the most comprehensive investigations to date into how specimen shipment, handling, and cryopreservation impact sperm quality and is expected to set a new benchmark for scientific rigor in the rapidly growing field of at-home fertility testing. This study is being conducted in collaboration with IVF Academy USA.

Raising the bar for clinical evidence in at-home fertility care

To date, validation work in at-home semen collection has been limited in important ways. Studies have largely enrolled normozoospermic men only, relied on courier-transported rather than real-world-shipped specimens, and focused on short-term motility and concentration as primary endpoints.

Critical questions remain unanswered, particularly around how samples with varying quality perform under genuine end-to-end shipping conditions, and how those samples hold up in the contexts that matter most clinically: IVF and IUI. The Sperm Study is designed to close those gaps.

This multi-phase study will evaluate key sperm quality parameters including motility, DNA fragmentation, and post-thaw viability, while also validating the use of computer-aided semen analysis (CASA) as an alternative to basic manual semen analysis in the setting of mail-in semen analysis.

“With the increased utilization of at-home semen testing and cryopreservation, there is a critical need to ensure these specimens will perform adequately when used for assisted reproduction,” said Legacy’s Chief Medical Officer, Dr. Scott Lundy. “This study is designed to rigorously evaluate how at-home collection and transport impact sperm quality across a broad patient population and to translate those findings into improved protocols and optimized outcomes for both patients and providers.”

Sperm study design and scientific approach

The Sperm Study is a prospectively accruing cross-sectional study in which paired semen samples are analyzed across multiple timepoints and during the shipment process. Importantly, this study enrolls participants across a range of semen quality profiles — not solely normozoospermic men — and evaluates samples under genuine shipping conditions experienced by real specimens.

Key study components include direct comparison of CASA vs. manual analysis at baseline, evaluation of motility decline over time and in relation to shipment conditions, measurement of DNA fragmentation pre- and post-shipment and cryopreservation, assessment of post-thaw sperm viability and yield, and the development of predictive algorithms for IVF/IUI sample sufficiency.

The study will also examine how factors such as transit time, concentration, and storage conditions impact outcomes, with the goal of generating generalizable insights for clinical practice.

Multi-phase rollout

Phase 1 includes 100 participants and approximately 1,500 total assays, with expected completion in 2026. Phase 2, planned for later in 2026 and into 2027, will expand the study with additional participants, bringing the total to up to 250 to enable broader validation across a more diverse patient population.

Impact on clinical practice

Findings from the Sperm Study are expected to directly inform and improve specimen collection protocols for at-home use, shipping and handling standards for semen samples, cryopreservation practices, and clinical decision-making for IVF and IUI readiness.

By generating high-quality, controlled data across a clinically representative patient population, Legacy aims to provide fertility clinics, researchers, and patients with greater confidence in the use of mail-in semen testing and cryopreservation as part of standard reproductive care.

About Legacy

Legacy is the leading male fertility clinic in the United States, offering at-home semen analysis, sperm cryopreservation, and post-vasectomy testing. With a CLIA-certified, high-complexity andrology lab and one of the largest proprietary datasets in male reproductive health, Legacy is advancing access, data, and innovation in fertility care.

View original content to download multimedia:https://www.prnewswire.com/news-releases/legacy-launches-1m-study-advancing-at-home-semen-collection-for-assisted-reproduction-technology-302768508.html

SOURCE Give Legacy, Inc.

Continue Reading

Technology

Elks Award Nearly $5 Million in College Scholarships

Published

on

By

CHICAGO, May 11, 2026 /PRNewswire/ — The Elks National Foundation welcomed 900 students to the Elks family, awarding more than $4.9 million in scholarships to high school seniors. An Elks scholarship is more than financial aid; it’s an invitation to a network of service-minded peers and a promise that an Elks Lodge is always there with open arms.

Out of more than 23,000 applicants for the Most Valuable Student scholarship, the Top 20 scholars received $30,000 scholarships and an invitation to Chicago for the Leadership Weekend.

From April 30-May 3, the Leadership Weekend allowed scholars to get acquainted with their new Elks family through programming facilitated by current and former Elks scholars, team-building activities, and a service opportunity.

“Leadership Weekend is one of my greatest memories,” says Emily Cai, sponsored by Toccoa, Ga., Lodge No. 1820. “I had the privilege of meeting inspirational and disciplined individuals who motivated me to become the best version of myself. I am excited to see my future with the Elks family!”

A total of 480 runners-up received $4,000 Most Valuable Student scholarships.

Service is a tenet of the Elks, which is why it’s a requirement for recipients of the $6,000 Legacy Awards scholarship, which is exclusively for the children or grandchildren of Elks members. The new class of 400 scholars will serve with an Elks Lodge three times during the four years they receive the scholarship.

“This award means a great deal to me and my family,” says Kelly Butler, sponsored by Haverstraw, N.Y., Lodge No. 877. “Knowing that the Elks have invested in my future motivates me to continue working hard and striving toward my goals.”

To see a full list of the scholarship winners and to learn more about the Elks National Foundation’s scholarships, visit elks.org/scholars, follow the ENF on Instagram @ElksScholars, and like the ENF on Facebook @ElksNationalFoundation.

Contact: Elks National Foundation
Abbey Knupp | Manager, Communications
2750 N. Lakeview Ave. | Chicago, IL 60614-2256
773/755-4864 | AbbeyK@elks.org 

Helping Elks Build Stronger Communities

The Elks National Foundation, the charitable arm of the Benevolent and Protective Order of Elks, helps nearly 800,000 Elks and nearly 1,800 Lodges nationwide build stronger communities through programs that support youth, serve veterans, and meet needs in areas where Elks live and work. To learn more, visit elks.org/enf.

View original content to download multimedia:https://www.prnewswire.com/news-releases/elks-award-nearly-5-million-in-college-scholarships-302768507.html

SOURCE ELKS NATIONAL FOUNDATION, INC.

Continue Reading

Trending